v3.25.2
Condensed Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2023 $ 1 $ 38,404 $ (41,405) $ (3,000)
Balance, shares at Dec. 31, 2023 10,693,580        
Issuance of common stock upon exercise of stock options 42 42
Issuance of common stock upon exercise of stock options, shares   38,981        
Stock-based compensation expense 423 423
Net loss (1,076) (1,076)
Issuance of common stock upon the private placement offering $ 1 5,377 5,378
Issuance of common stock upon the private placement offering, shares   6,133,414        
Balance at Mar. 31, 2024 $ 2 44,246 (42,481) 1,767
Balance, shares at Mar. 31, 2024 16,865,975        
Balance at Dec. 31, 2023 $ 1 38,404 (41,405) (3,000)
Balance, shares at Dec. 31, 2023 10,693,580        
Net loss           (3,465)
Balance at Jun. 30, 2024 $ 2 54,140 (44,870) 9,272
Balance, shares at Jun. 30, 2024 23,970,067        
Balance at Mar. 31, 2024 $ 2 44,246 (42,481) 1,767
Balance, shares at Mar. 31, 2024 16,865,975        
Issuance of restricted stock awards
Issuance of restricted stock awards, shares   120,000        
Issuance of common stock upon exercise of stock options 12 12
Issuance of common stock upon exercise of stock options, shares   23,228        
Stock-based compensation expense 244 244
Net loss (2,389) (2,389)
Issuance of common stock upon the private placement offering 9,638 9,638
Issuance of common stock upon the private placement offering, shares   6,960,864        
Balance at Jun. 30, 2024 $ 2 54,140 (44,870) 9,272
Balance, shares at Jun. 30, 2024 23,970,067        
Balance at Dec. 31, 2024 $ 2 54,695 (50,219) 4,478
Balance, shares at Dec. 31, 2024 24,034,672        
Issuance of common stock upon equity financing, net of issuance cost $ 2 10,801   10,803
Issuance of common stock upon equity financing, net of issuance cost, shares   11,523,810        
Issuance of common stock upon exercise of common warrants    
Issuance of common stock upon exercise of common warrants, shares   951,500        
Issuance of restricted stock awards  
Issuance of restricted stock awards, shares   30,000        
Issuance of common stock upon exercise of stock options   8   8
Issuance of common stock upon exercise of stock options, shares   6,770        
Stock-based compensation expense 288   288
Net loss (2,420) (2,420)
Balance at Mar. 31, 2025 $ 4 65,792 (52,639) 13,157
Balance, shares at Mar. 31, 2025 36,546,752        
Balance at Dec. 31, 2024 $ 2 54,695 (50,219) $ 4,478
Balance, shares at Dec. 31, 2024 24,034,672        
Issuance of common stock upon exercise of stock options, shares           39,650
Net loss           $ (5,315)
Balance at Jun. 30, 2025 $ 4 66,171 (55,534) 10,641
Balance, shares at Jun. 30, 2025 36,645,884        
Balance at Mar. 31, 2025 $ 4 65,792 (52,639) 13,157
Balance, shares at Mar. 31, 2025 36,546,752        
Issuance of common stock upon exercise of common warrants 25   25
Issuance of common stock upon exercise of common warrants, shares   25,252        
Issuance of restricted stock awards  
Issuance of restricted stock awards, shares   41,000        
Issuance of common stock upon exercise of stock options 9   9
Issuance of common stock upon exercise of stock options, shares   32,880        
Stock-based compensation expense 345   345
Net loss (2,895) (2,895)
Balance at Jun. 30, 2025 $ 4 $ 66,171 $ (55,534) $ 10,641
Balance, shares at Jun. 30, 2025 36,645,884